venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 10
- +2 vs. Q1 2021
- Portfolio value
- $847.2M
- −$205.1M (−19.5%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $530.4M | 62.6% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 3,504,624 | $98.9M | 11.7% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 2,200,778 | $54.6M | 6.4% | −243,533−10.0% | Reduced | History |
| PHVSPharvaris N.V. | COM | 2,303,310 | $42.9M | 5.1% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 2,608,167 | $35.4M | 4.2% | +2,608,167 | New | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 411,471 | $26.0M | 3.1% | −79,000−16.1% | Reduced | History |
| IMPLIPI Legacy Liquidation Co | COM | 2,759,791 | $24.4M | 2.9% | +2,759,791 | New | History |
| CMPICheckmate Pharmaceuticals, Inc. | COM | 3,673,374 | $21.9M | 2.6% | 00.0% | Unchanged | History |
| MTCRMetacrine, Inc. | COM | 3,059,123 | $11.6M | 1.4% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 161,897 | $1.06M | 0.1% | 00.0% | Unchanged | History |